Calmare Therapeutics Inc (CTTC.PK) Company Profile | Reuters.com
Edition:
United States

Profile: Calmare Therapeutics Inc (CTTC.PK)

CTTC.PK on OTC Markets Group

0.23USD
27 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,115
52-wk High
$0.36
52-wk Low
$0.11

Calmare Therapeutics Incorporated (CTI), incorporated on August 12, 1971, is a medical device company. The Company is engaged in developing and commercializing products and technologies for chronic neuropathic pain and wound care affliction patients. The Company's medical device, the Calmare Pain Therapy Device (the Calmare Device), is a non-invasive and non-addictive modality that can treat chronic, neuropathic pain. Its medical devices offer a non-pharmacological (no drugs), non-addictive (no narcotics) and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. Its subsidiary is Vector Vision, Inc.

The Company offers a portfolio of technologies in life, electronic, nano and physical sciences. The Company's technology portfolio includes CALMARE pain therapy treatment, neuroprotection and cognitive enhancement, sexual dysfunction therapeutic, skin pigment enhancer, wound sealant, preparation of ordered multi-layer films, silica thin films, structural steel fissure detection paint, public key encryption, growing single crystals, and video compression and moving picture experts group (MPEG)-4. Its pain therapy technology is a non-invasive method for treatment of oncologic, neuropathic, and drug-resistant pain through a biophysical rather than a biochemical manner.

Company Address

Calmare Therapeutics Inc

1375 Kings Hwy
FAIRFIELD   CT   06824-5318
P: +1203.3686044
F: +1203.3685399

Company Web Links